Phase III randomized trial of high-dose chemotherapy (HDC) and peripheral blood stem cell (PBSC) support as consolidation in patients (pts) with advanced ovarian cancer (AOC): 5-year follow-up of a GINECO/FNCLCC/SFGM-TC study

2004 ◽  
Vol 22 (14_suppl) ◽  
pp. 5006-5006 ◽  
Author(s):  
H. Cure ◽  
C. Battista ◽  
J. P. Guastalla ◽  
M. Fabbro ◽  
N. Tubiana ◽  
...  
Sign in / Sign up

Export Citation Format

Share Document